DETAILS, FICTION AND API MANUFACTURING

“The existing scenario has uncovered some structural weaknesses within the EU’s medicines provide chain and a large dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides stated. She recommended that supply chain difficulties be dealt with in an EU pharmaceutical system envisioned to get introduced by